Malin Nittve

发表

Neuropathy experienced by colorectal cancer patients receiving oxaliplatin: A qualitative study to validate the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity scale

D. Cella, S. Shaunfield, K. Kaiser, 2020, World journal of gastrointestinal oncology.

Persistent prevention of oxaliplatin-induced peripheral neuropathy using calmangafodipir (PledOx®): a placebo-controlled randomised phase II study (PLIANT)

D. Mahalingam, B. Glimelius, P. Pfeiffer, 2017, Acta oncologica.